Variant report
Variant | esv12734 |
---|---|
Chromosome Location | chr5:8775955-8780362 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2904951 | chr5:8775997-8775998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs2904950 | chr5:8776002-8776003 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs148985261 | chr5:8776025-8776026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561469322 | chr5:8776027-8776028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574421031 | chr5:8776036-8776037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547500871 | chr5:8776038-8776039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190093566 | chr5:8776061-8776062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116076170 | chr5:8776073-8776074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75034901 | chr5:8776082-8776083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559182917 | chr5:8776097-8776098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528373464 | chr5:8776101-8776102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34177325 | chr5:8776110-8776111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547957399 | chr5:8776118-8776119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116392794 | chr5:8776123-8776124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138320289 | chr5:8776145-8776146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143856163 | chr5:8776162-8776163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112970201 | chr5:8776268-8776269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147235944 | chr5:8776363-8776364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs56009636 | chr5:8776413-8776414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs397711393 | chr5:8776414-8776415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369039579 | chr5:8776415-8776416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202074271 | chr5:8776417-8776418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs202212772 | chr5:8776418-8776419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200528116 | chr5:8776419-8776420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2904949 | chr5:8776426-8776427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138132420 | chr5:8776428-8776429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148780899 | chr5:8776429-8776430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11748315 | chr5:8776430-8776431 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs397958217 | chr5:8776437-8776438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201340679 | chr5:8776448-8776449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535361170 | chr5:8776450-8776451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34035799 | chr5:8776468-8776469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554829126 | chr5:8776471-8776472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575011152 | chr5:8776503-8776504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543150584 | chr5:8776504-8776505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs56702810 | chr5:8776524-8776525 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs549863088 | chr5:8776535-8776536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149418118 | chr5:8776546-8776547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545347239 | chr5:8776573-8776574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566334663 | chr5:8776597-8776598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536958723 | chr5:8776598-8776599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558948549 | chr5:8776611-8776612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182621655 | chr5:8776612-8776613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541758939 | chr5:8776636-8776637 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561713516 | chr5:8776638-8776639 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186598424 | chr5:8776646-8776647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2938829 | chr5:8776664-8776665 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs191334654 | chr5:8776674-8776675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537984747 | chr5:8776714-8776715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185437859 | chr5:8776722-8776723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:8775200-8776200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:8775200-8776200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr5:8775200-8776200 | Enhancers | Osteobl | bone |
4 | chr5:8775200-8776400 | Enhancers | Placenta Amnion | Placenta Amnion |
5 | chr5:8775200-8776600 | Enhancers | HMEC | breast |
6 | chr5:8775200-8777800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr5:8775400-8776000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr5:8775400-8776200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr5:8775400-8776200 | Enhancers | NH-A | brain |
10 | chr5:8775400-8776400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr5:8775600-8776200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr5:8775800-8776200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr5:8776200-8777200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr5:8776600-8777000 | Weak transcription | HMEC | breast |
15 | chr5:8777000-8778000 | Enhancers | HMEC | breast |
16 | chr5:8777200-8777600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |